Evidence map›Paper›PMID 35257441›Full record

ArticleJournal of cardiovascular electrophysiology2022

Strategies for repeat ablation for atrial fibrillation: A multicentre comparison of nonpulmonary vein versus pulmonary vein target ablation.

Daniel Mol, Mark J Mulder, Rob Veenstra, Cornelis P Allaart, Irene E Hof, Michiel J B Kemme, Muchtiar Khan, Geert-Jan P Kimman, Gideon Mairuhu, Gijsbert S de Ruiter and 3 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of cardiovascular electrophysiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Outcomes after redo ablation for the recurrence of atrial fibrillation: a systematic review and meta-analysis.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  3. Article
  4. Silent pulmonary veins at redo ablation for atrial fibrillation: Implications and approaches.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  5. Electrogram morphology recurrence guided catheter ablation for repeat ablation of persistent atrial fibrillation.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Daniel MolDepartment of Cardiology, OLVG, Amsterdam, The Netherlands.ORCID 0000-0002-0746-4903
Mark J MulderDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Rob VeenstraDepartment of Cardiology, OLVG, Amsterdam, The Netherlands.
Cornelis P AllaartDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Irene E HofDepartment of Cardiology, OLVG, Amsterdam, The Netherlands.
Michiel J B KemmeDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Muchtiar KhanDepartment of Cardiology, OLVG, Amsterdam, The Netherlands.
Geert-Jan P KimmanDepartment of Cardiology, OLVG, Amsterdam, The Netherlands.
Gideon MairuhuDepartment of Cardiology, OLVG, Amsterdam, The Netherlands.
Gijsbert S de RuiterDepartment of Cardiology, OLVG, Amsterdam, The Netherlands.
Giovanni J M TahaparyDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Joris R de GrootDepartment of Cardiology, Amsterdam University Medical Centres, Amsterdam, The Netherlands.ORCID 0000-0002-8122-7017
Jonas S S G de JongDepartment of Cardiology, OLVG, Amsterdam, The Netherlands.ORCID 0000-0003-2544-5279
OLVG · NLAmsterdam University Medical Centers · NLNoordwest Ziekenhuisgroep · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionApproximately 18% of patients with atrial fibrillation (AF) undergo a repeat ablation within 12 months after their index ablation. Despite the high prevalence, comparative studies on nonpulmonary vein (PV) target strategies in repeat AF ablation are scarce. Here, we describe 12 months efficacy of non-PV and PV target ablations as a repeat ablation strategy.

methodsA multicentre retrospective, descriptive study was conducted with data of 280 patients who underwent repeat AF ablation. The ablation strategy for repeat ablation was at the operators' discretion. Non-PV target ablation (n = 140) included PV reisolation, posterior wall isolation, mitral line, roofline, and/or complex fractionated atrial electrogram ablation. PV target ablation (n = 140), included reisolation and/or wide atrium circumferential ablation. Patients' demographics and rhythm outcomes during 12 months follow-up were analyzed.

resultsAt 12 months, more atrial tachyarrhythmias were observed in the non-PV target group (48.6%) compared to the PV target group (29.3%, p = .001). Similarly, a significantly higher AF and atrial tachycardia (AT) recurrence rate was observed after non-PV target ablation compared to PV target ablation (36.4% vs. 22.1% and 22.9% vs. 10.7%). After adjustment, a significantly higher risk of AT recurrence remained in the non-PV target group. Both groups significantly de-escalated antiarrhythmic drug use; de-escalation was more profound after PV target ablation. Patients with isolated PVs during non-PV target ablation had a significantly higher risk for AF recurrence than those with reconnected PVs.

conclusionCompared to PV target ablation, non-PV target repeat ablation did not improve outcomes after 12 months and was independently associated with an increased risk for AT recurrences.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsHumansRecurrenceRetrospective StudiesTreatment Outcomeatrial fibrillationnonpulmonary vein target ablationrepeat ablation

Identifiers

PMID35257441
PMCPMC9315029
OpenAlexW4220912376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.